CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Martin A. Cheever
Fred Hutchinson Cancer Research Center/Cancer Immunotherapy Trials Network
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Ucsf Medical Center-Mission Bay
San Francisco, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Emory University/winship Cancer Institute
Atlanta, Georgia, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Laura and Isaac Perlmutter Cancer Center at Nyu Langone
New York, New York, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
- University of Washington Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Sept 2013
- Primary completion
- 15 May 2017
- Completion
- 2 Jan 2018
- Last update posted
- 9 Jul 2019
- Registered enrollment
- 54
- Registry id
- NCT01881867
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.